As one of the “pharmerging countries”, China represents a fascinating new frontier and an enormous challenge to pharmaceutical companies as we move into 2009. A land of contradictions due to its vast size and rapidly changing systems, it is a market that can not be ignored.
Medimix International has seen its business in Asia increase three-fold in the last two years and has responded with the opening of a new regional office, Medimix Asia, in the Wanchai district of Hong Kong, with satellite offices in Shanghai, Beijing, and Singapore, serving both the Asian headquarters of life science companies, as well as their Chinese subsidiaries.
For more details on Medimix's services in Asia, please consult the attached release.
To learn more about Medimix International go to www.medimix.net
